BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12072783)

  • 1. Bleomycin-induced alveolitis detected by FDG positron emission tomography.
    Hain SF; Beggs AD
    Clin Nucl Med; 2002 Jul; 27(7):522-3. PubMed ID: 12072783
    [No Abstract]   [Full Text] [Related]  

  • 2. Lungs on fire.
    Batra S; Vaid AK; Bhargava R; Gupta S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.
    Kirsch J; Arrossi AV; Yoon JK; Wu G; Neumann DR
    J Thorac Imaging; 2006 Aug; 21(3):228-30. PubMed ID: 16915070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma.
    Falay O; Öztürk E; Bölükbaşı Y; Gümüş T; Örnek S; Özbalak M; Çetiner M; Demirkol O; Ferhanoğlu B
    Leuk Lymphoma; 2017 May; 58(5):1114-1122. PubMed ID: 28185527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin Toxicity - Findings on FDG PET CT.
    Mufty S; Razi M; Hassan A
    J Pak Med Assoc; 2021 Sep; 71(9):2287-2288. PubMed ID: 34580536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lung disease due to bleomycin (proceedings)].
    De Maria D; Pantusa M; Falchi AM
    Radiol Med; 1977 Apr; 63(4):360-3. PubMed ID: 73204
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the early diagnosis of asymptomatic bleomycin-induced pneumonitis.
    Connerotte T; Lonneux M; de Meeûs Y; Hermans C; Vekemans MC; Ferrant A; Van Den Neste E
    Ann Hematol; 2008 Nov; 87(11):943-5. PubMed ID: 18443792
    [No Abstract]   [Full Text] [Related]  

  • 8. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
    Buchler T; Bomanji J; Lee SM
    Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
    Ciammella P; Filippi AR; Simontacchi G; Buglione M; Botto B; Mangoni M; Iotti C; Merli F; Marcheselli L; Bisi G; Ricardi U; Versari A
    Br J Radiol; 2016; 89(1061):20150983. PubMed ID: 27022777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
    Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S
    Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin-induced pulmonary toxicity.
    Jules-Elysee K; White DA
    Clin Chest Med; 1990 Mar; 11(1):1-20. PubMed ID: 1691067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible interstitial pneumonitis associated with low dose bleomycin.
    O'Neill TJ; Kardinal CG; Tierney LM
    Chest; 1975 Aug; 68(2):265-7. PubMed ID: 50163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
    J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bleomycin-induced lung changes in the roentgen picture].
    Umek H; Dupal HD
    Rofo; 1976 Dec; 125(6):532-7. PubMed ID: 64443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis on F-18 FDG positron emission tomography.
    Lyburn ID; Lowe JE; Wong WL
    Clin Nucl Med; 2005 Jan; 30(1):27. PubMed ID: 15604964
    [No Abstract]   [Full Text] [Related]  

  • 17. Early warning signs: FDG-PET to diagnose bleomycin toxicity.
    Dickinson M; Irving L; Hofman M
    Leuk Lymphoma; 2017 May; 58(5):1016-1018. PubMed ID: 28185528
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response.
    Iacovino JR; Leitner J; Abbas AK; Lokich JJ; Snider GL
    JAMA; 1976 Mar; 235(12):1253-5. PubMed ID: 55505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal pulmonary fibrosis after a low cumulated dose of bleomycin: role of alpha1-antitrypsin deficiency?
    Alliot C; Tabuteau S; Desablens B; Aubry P; Andrejak M
    Am J Hematol; 1999 Nov; 62(3):198-9. PubMed ID: 10539931
    [No Abstract]   [Full Text] [Related]  

  • 20. Procarbazine-induced interstitial pneumonitis with a normal chest x-ray: a case report.
    Garbes ID; Henderson ES; Gomez GA; Bakshi SP; Parthasarathy KL; Castillo NB
    Med Pediatr Oncol; 1986; 14(4):238-41. PubMed ID: 3747943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.